EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correction: Canar et al. STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor Signaling. Curr. Oncol. 2025, 32, 707

Jorge Canar, Madeline Bono, Amy Alvarado, Michael Slifker, Giovanni Sitia, Ana M. Gamero

Current Oncology · 04.11.2026 · 33 (11) · 675

DOI: 10.3390/curroncol33110675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 04.11.2026. Verfasst von Jorge Canar und 5 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute, National Institute of General Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the original publication [...]

Förderung

  • National Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

Canar, J., Bono, M., Alvarado, A., Slifker, M., Sitia, G., & Gamero, A. M. (2026). Correction: Canar et al. STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor Signaling. Curr. Oncol. 2025, 32, 707. Current Oncology, 33(11), 675. https://doi.org/10.3390/curroncol33110675

Vancouver

Canar J, Bono M, Alvarado A, Slifker M, Sitia G, Gamero AM. Correction: Canar et al. STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor Signaling. Curr. Oncol. 2025, 32, 707. Current Oncology. 2026;33(11):675. doi:10.3390/curroncol33110675

BibTeX
@article{Canar2026,
  author = {Canar, Jorge and Bono, Madeline and Alvarado, Amy and Slifker, Michael and Sitia, Giovanni and Gamero, Ana M.},
  title = {Correction: Canar et al. STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor Signaling. Curr. Oncol. 2025, 32, 707},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {11},
  pages = {675},
  doi = {10.3390/curroncol33110675}
}
Kostenlos starten →